BioInvent International (Sweden) Profile

2.42
SEK 0.05  2.11%
100%
68%

BioInvent International Summary

BioInvent International AB (BINV) is traded on Stockholm Stock Exchange in Sweden. It is located in The Gamma Building and employs 59 people. The company currently falls under 'Small-Cap' category with current market capitalization of 792.81 M. BioInvent International AB operates under Healthcare sector and is part of Pharmaceuticals And Biosciences industry. This company has 350.8 M outstanding shares. BIOINVENT has accumulated about 108.15 M in cash with (175.17 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.31.
Check BioInvent International Probability Of Bankruptcy

Target Price Odds Analysis

Odds Below 2.42HorizonTargetOdds Above 2.42
98.37%30 days 2.42 1.58%
Based on normal probability distribution, the odds of BioInvent International to move above current price in 30 days from now is about 1.58% (This BioInvent International AB probability density function shows the probability of BioInvent International Stock to fall within a particular range of prices over 30 days) .

BioInvent International Risk Profiles

Key Fundamentals

BioInvent International Against Markets

Current Ratings

BioInvent International 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
10 
Chance of
Financial Distress (0 to 100%)
72 
Equity ratings for BioInvent International AB are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
BioInvent International AB focuses on the discovery and development of antibody-based drugs against cancer. The Company was founded in 1997 and is based in Lund, Sweden. BioInvent International operates under Biotechnology classification in Sweden and traded on Stockholm Stock Exchange. It employs 59 people. more
NameBioInvent International AB
President CEOMichael OredssonView All
Macroaxis Advice
Specialization
Healthcare, Pharmaceuticals And Biosciences
InstrumentSweden Stock View All
Business AddressThe Gamma Building
ExchangeStockholm Stock Exchange
ISINSE0000789711
SectorHealthcare
IndustryPharmaceuticals And Biosciences
BenchmarkDOW
Websitewww.bioinvent.com
Phone46 4 62 86 85 50
CurrencySEK - Swedish Kronor

Directors

BioInvent International Corporate Directors
Jonas Jendi Director
Lars Ingelmark Independent Member of the Board of Directors
Martin Nicklasson Director
Check also Trending Equities. Please also try Transaction History module to view history of all your transactions and understand their impact on performance.